Detalhe da pesquisa
1.
Subcutaneous immunoglobulin replacement following CD19-specific chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia in pediatric patients.
Pediatr Blood Cancer
; 67(3): e28092, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31793170
2.
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.
Blood
; 128(3): 360-70, 2016 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27166358